OCREVUS 300 mg concentrate for solution for infusion *

  • Company:

    Roche Registration GmbH
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

Licence number Strength ATC code Dosage form EU/1/17/1231/001-002 300 milligram(s) L04AA,L04AA36 Concentrate for solution for infusion